Objectives A major challenge for COVID-19 therapy is dysregulated immune response
associated with the disease. Umbilical cord mesenchymal stromal cells (UC-MSCs) may be …

Acute respiratory distress syndrome (ARDS) is a life-threatening lung disease. It may occur
during the pancytopenia phase following allogeneic hematopoietic cell transplantation …

Coronavirus disease 2019 (COVID-19)-related respiratory failure is a significant cause of
morbidity, mortality and health care utilization. Further, long-term respiratory consequences …

ABSTRACT Introduction Acute Respiratory Distress Syndrome (ARDS) is a heterogeneous
form of lung injury with severe hypoxemia and bilateral infiltrates after an inciting event that …

Asthma is a complex and heterogeneous disease characterized by chronic airway
inflammation, airway hyperresponsiveness, and airway remodeling. Most asthmatic patients …

Abstract Background Coronavirus disease‐19 (COVID‐19) is a zoonotic disease that has
become a global pandemic. The fast evolution of the COVID‐19 pandemic and persist …

Background Global pandemic identified as coronavirus disease 2019 (COVID-19) has
resulted in a variety of clinical symptoms, from asymptomatic carriers to those with severe …

The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), emerged in 2019 following prior outbreaks of coronaviruses like SARS and …

Background Treatment options for patients with COVID-19-related acute respiratory distress
syndrome (ARDS) are desperately needed. Allogeneic human umbilical cord derived …

Considerable experimental evidence has indicated that allogeneic mesenchymal stromal
cells (MSCs) isolated from bone marrow or umbilical cord might be effective for treating …